S. Tchilibon

发表

Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5'-triphosphate analogues at the human P2Y2 and P2Y4 receptors.

K. Jacobson, Zhang-Guo Gao, T. K. Harden, 2006, Biochemical pharmacology.

A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis.

M. Feldmann, R. Mechoulam, S. Tchilibon, 2004, Arthritis and rheumatism.

Chapter 13. A3 Adenosine Receptors.

K. Jacobson, Zhang-Guo Gao, B. Joshi, 2003, Annual Reports in Medicinal Chemistry.

Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor.

K. Jacobson, T. K. Harden, B. Joshi, 2004, Biochemical pharmacology.

2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding.

K. Jacobson, Zhang-Guo Gao, L. Mamedova, 2004, Biochemical pharmacology.

Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands.

Kenneth A Jacobson, K. Jacobson, Zhang-Guo Gao, 2004, Bioorganic & medicinal chemistry.

Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.

K. Jacobson, S. Costanzi, B. Joshi, 2004, Current topics in medicinal chemistry.

Amphiphilic pyridinium salts block TNF alpha/NF kappa B signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cells.

K. Jacobson, O. Eidelman, H. Pollard, 2005, Biochemical pharmacology.

Stereochemistry of the Baker′s Yeast Mediated Reduction of the C=C Bond of (Z)‐ and (E)‐5‐Benzoyloxyhex‐3‐en‐2‐one.

R. Rallo, C. Fuganti, P. Grasselli, 1995 .

Stereochemistry of the baker's yeast mediated reduction of the CC bond of (Z)- and (E)-5-benzoyloxyhex-3-en-2-one

R. Rallo, C. Fuganti, P. Grasselli, 1994 .

Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors.

Raphael Mechoulam, D. Ponde, R. Mechoulam, 2005, Organic & biomolecular chemistry.

Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position.

K. Jacobson, Philippe van Rompaey, S. van Calenbergh, 2004, Bioorganic & medicinal chemistry.

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

D. Ponde, T. Bisogno, R. Mechoulam, 2001, British journal of pharmacology.

Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.

K. Jacobson, Zhang-Guo Gao, B. Joshi, 2005, Journal of medicinal chemistry.

(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.

K. Jacobson, Zhang-Guo Gao, B. Joshi, 2005, Journal of medicinal chemistry.

Amphiphilic pyridinium salts block TNFα/NFκB signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cells

K. Jacobson, O. Eidelman, H. Pollard, 2005 .

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.

R. Mechoulam, L. Hanuš, A. Breuer, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Action of Nucleosides and Nucleotides at 7 Transmembrane-Spanning Receptors

K. Jacobson, Zhang-Guo Gao, S. Costanzi, 2006, Nucleosides, nucleotides & nucleic acids.

A neoceptor approach to unraveling microscopic interactions between the human A2A adenosine receptor and its agonists.

K. Jacobson, Zhang-Guo Gao, S. Tchilibon, 2005, Chemistry & biology.

Synthesis of a primary metabolite of cannabidiol.

R. Mechoulam, S. Tchilibon, 2000, Organic letters.